Cytochromes P450 as targets to autoantibodies in immune mediated diseases.
Boitier
E
E
Beaune
P
P
D000927:Anticonvulsants / Q000009:adverse effects; D001323:Autoantibodies / Q000378:metabolism*; D056486:Chemical and Drug Induced Liver Injury / Q000276:immunology*; D003577:Cytochrome P-450 Enzyme System / Q000276:immunology*; D004078:Dihydralazine / Q000633:toxicity; D006221:Halothane / Q000633:toxicity; D019693:Hepatitis, Autoimmune / Q000235:genetics / Q000276:immunology*; D006801:Humans; D018716:Molecular Mimicry; D016884:Polyendocrinopathies, Autoimmune / Q000276:immunology*; D013989:Ticrynafen / Q000633:toxicity
D000927:Anticonvulsants; D001323:Autoantibodies; D003577:Cytochrome P-450 Enzyme System; D013989:Ticrynafen; D004078:Dihydralazine; D006221:Halothane